• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单抗原流珠检测中补体干扰现象的流行率、分布和幅度。

Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays.

机构信息

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.

Université de Bordeaux, Bordeaux, France.

出版信息

HLA. 2018 Jun;91(6):507-513. doi: 10.1111/tan.13263.

DOI:10.1111/tan.13263
PMID:29604172
Abstract

HLA antibody detection with single antigen flow beads (SAFB) assays is impaired by complement interference whose frequency, predictability and distribution among HLA antigens have not been analyzed in large cohorts. We compared in two patients' cohorts the routine follow-up SAFB profiles obtained in class I (n = 129) and class II (n = 85) with and without ethylenediaminetetraacetic acid (EDTA)-treatment. The presence of complement interference was defined according to the reproducibility of the SAFB assays evaluated with our class I and II routine positive control sera. Interference occurred in 29.5% and 45.9% of patients in class I and II, respectively. In the untreated condition, at serum level, neither the number of positive beads, the highest bead mean fluorescence intensity (MFI) nor MFI at bead level, satisfactorily predicted interference. HLA-C were the least affected among class I beads. HLA-DQ beads were the most affected in class II. At least one antibody specificity was falsely negative without EDTA for about 3% of sera in class I and 9% in class II. EDTA-treatment did not significantly modify the low-MFI strengths (500-3000 range). This study emphasizes the high frequency of complement interference and the importance and advantages of systematically pretreating sera with EDTA before performing SAFB assays.

摘要

HLA 抗体的单抗原流(SAFB)检测会受到补体干扰的影响,但其在大样本中的频率、可预测性和在 HLA 抗原中的分布尚未得到分析。我们在两名患者队列中比较了未经 EDTA 处理(n=129)和经 EDTA 处理(n=85)的 I 类和 II 类 SAFB 常规随访谱。根据我们的 I 类和 II 类常规阳性对照血清评估的 SAFB 检测的可重复性来定义补体干扰的存在。在 I 类和 II 类患者中,分别有 29.5%和 45.9%的患者存在干扰。在未经处理的情况下,血清水平上,阳性珠的数量、最高珠平均荧光强度(MFI)或珠水平上的 MFI 均不能很好地预测干扰。I 类珠中 HLA-C 受影响最小。在 II 类中,HLA-DQ 珠受影响最大。约有 3%的 I 类血清和 9%的 II 类血清未经 EDTA 处理时,至少有一种抗体特异性呈假阴性。EDTA 处理并没有显著改变低 MFI 强度(500-3000 范围)。本研究强调了补体干扰的高频率,以及在进行 SAFB 检测前系统地用 EDTA 预处理血清的重要性和优势。

相似文献

1
Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays.单抗原流珠检测中补体干扰现象的流行率、分布和幅度。
HLA. 2018 Jun;91(6):507-513. doi: 10.1111/tan.13263.
2
The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.补体干扰现象导致肾移植患者血清抗 HLA 抗体强度急剧波动。
Transpl Immunol. 2013 Dec;29(1-4):17-21. doi: 10.1016/j.trim.2013.09.005. Epub 2013 Sep 20.
3
Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.有的放矢:新型、抗前带效应、双抗体快速检测(DART)试剂用于 LABScreen 单抗原珠(SAB)检测试剂的开发。
Hum Immunol. 2019 Jul;80(7):468-477. doi: 10.1016/j.humimm.2019.04.017. Epub 2019 Apr 28.
4
The ABCs (DRDQDPs) of the prozone effect in single antigen bead HLA antibody testing: Lessons from our highly sensitized patients.单抗原珠 HLA 抗体检测中前带效应的 ABCs(DRDQDPs):来自我们高度致敏患者的经验教训。
Hum Immunol. 2019 Jul;80(7):478-486. doi: 10.1016/j.humimm.2019.04.019. Epub 2019 May 10.
5
Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.使用Luminex I类单抗原流式微球分析法对T淋巴细胞交叉配型结果预测的重新评估
Transplantation. 2017 Mar;101(3):624-630. doi: 10.1097/TP.0000000000001239.
6
Investigating complement mediated interference in class I HLA-specific antibodies following renal transplantation.研究肾移植后补体介导的Ⅰ类 HLA 特异性抗体干扰。
Transpl Immunol. 2020 Oct;62:101310. doi: 10.1016/j.trim.2020.101310. Epub 2020 Jun 20.
7
Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays.解析流式微球检测抗人白细胞抗原抗体时补体干扰。
Transplantation. 2014 Sep 27;98(6):625-31. doi: 10.1097/TP.0000000000000315.
8
Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays.利用流式微球分析法解析IgM在IgG抗HLA抗体检测中的干扰作用。
Hum Immunol. 2016 Nov;77(11):1048-1054. doi: 10.1016/j.humimm.2016.02.008. Epub 2016 Feb 20.
9
[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.[C4d]FlowPRA筛查——一种用于选择性检测补体激活抗HLA同种抗体的特异性检测方法。
Hum Immunol. 2005 May;66(5):526-34. doi: 10.1016/j.humimm.2004.12.007. Epub 2005 Feb 12.
10
Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.用于检测补体结合HLA特异性抗体的C1q单抗原珠试验的技术局限性
Transplantation. 2017 Jun;101(6):1206-1214. doi: 10.1097/TP.0000000000001270.

引用本文的文献

1
Measurement of the Immunosuppressant Possession Ratio by Transplant Clinical Pharmacists Captures a Non-Adherence Associated With Antibody-Mediated Rejection.移植临床药师通过测量免疫抑制剂持有率来捕捉与抗体介导的排斥反应相关的不依从性。
Transpl Int. 2023 Nov 28;36:11962. doi: 10.3389/ti.2023.11962. eCollection 2023.
2
Utilizing proficiency testing survey data to create advanced educational content: the virtual crossmatch challenge model.利用能力验证调查数据创建高级教育内容:虚拟交叉配型挑战模型。
Front Genet. 2023 Sep 21;14:1256498. doi: 10.3389/fgene.2023.1256498. eCollection 2023.
3
EDTA Treatment for Overcoming the Prozone Effect and for Predicting C1q Binding in HLA Antibody Testing.
EDTA 处理克服前带效应和预测 HLA 抗体检测中 C1q 结合。
Ann Lab Med. 2019 Nov;39(6):572-576. doi: 10.3343/alm.2019.39.6.572.
4
Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.在 Luminex 平台上使用两种不同的二级抗体监测不同 beadset 观察到的肾病患者 HLA IgG 抗体个体内变异的意义。
Immunol Res. 2018 Oct;66(5):584-604. doi: 10.1007/s12026-018-9027-2.